FDA Turns Down AMGN's Osteoporosis Drug, EBS Opens Wallet, TROV Plunges

Today's Daily Dose brings you news about FDA's rejection of Amgen's osteoporosis drug EVENITY; Trovagene's stock offering and Emergent Bio's acquisition of smallpox vaccine business from Sanofi.

from RTT - Biotech http://ift.tt/2utmznE
via IFTTT